NURPREQTEV
Live / Allowed — Approved for publication (as of 28 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99862579
- Mark type
- Word mark
- Filed
- 03 Jun 2026
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, and neurological diseases and disorders; Pharmaceutical preparations for the treatment of Guillain-Barré syndrome
Owner
- Annexon, Inc., Brisbane, CA, US
Prosecution history
- 28 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Sept 2026 — ASSIGNED TO EXAMINER
- 03 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Jun 2026 — NEW APPLICATION ENTERED